Mammotome
Leica Biosystems is a global leader in workflow solutions and automation. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. Our extensive product portfolio includes Mammotome breast biopsy devices, specimen radiograph system and tissue markers; distribution of Kubtec’s specimen radiograph systems; the Neoprobe gamma detection system; as well as distribution of the Sentimag platform including the Magseed marker for magnetic lesion localization and the Magtrace liquid marker for radiation-free sentinel lymph node biopsy. For more information, visit our Web site at www.mammotome.com.